KHABIBOV, M.,
GARIFULLIN, A.,
KHAMITOV, F.,
KHALIKOVA, L.,
BOUMBER, Y.,
KHADDOUR, K.,
FERNANDEZ, M.,
KUZNETSOVA, N.,
KIT, O.,
KHARIN, L. (2022)
therapeutic options may only
marginally prolong survival and the
current standard of therapy cures only a
Deal, C,
Steelman, J,
Vlachopapadopoulou, E,
Stawerska, R,
Silverman, LA;,
Phillip, M,
Kim, HS,
Ko, CW,
Malievskiy, O,
Cara, JF,
Roland, CL,
Taylor, CT,
Valluri, SR,
Wajnrajch, MP,
Pastrak, A,
Miller, BS (2022)
noninferiority
margin (−1.8 cm/year), demonstrating noninferiority of once-weekly somatrogon vs daily somatropin
Chmutin, G,
Antonov, G,
Chmutin, E,
Fedyanin, A,
Livshitz, M,
Oleynikov, B,
Zokhidov, Z,
Shumadalova, A (2022) of patient investigation to optimize the choice of the most effective methods of
surgical treatment for VBI
Farkhshatova, R,
Gerasimova, L,
Usmanova, I,
Daurova, F,
Golub, A,
Aletdinova, S (2022) grafts
in
surgical methods of treating Miller class I gingival recession.
As the results, in the period
Djumanov, Kamaliddin,
Kariev, Gayrat,
Chmutin, Gennady,
Antonov, Gennady,
Chmutin, Egor,
Musa, Gerald,
Maier, Adam,
Shumadalova, Alina (2022) of postoperative morbidity associated with intramedullary tumors makes the need for safer
surgical techniques
Особенности хирургического лечения нейрофиброматоза I типаQuestions on
surgical treatment of neurofibromatosis type 1
Общехирургическая помощь населению: станет ли приоритетом в системе здравоохранения?Timerbulatov, Vil M.,
Viktorov, Vitaly V.,
Timerbulatov, Mahmud V.,
Nizamutdinov, Timur R.,
Timerbulatov, Shamil V.,
Sibaev, Vazir M.,
Тимербулатов, В. М.,
Викторов, В. В.,
Тимербулатов, М. В.,
Низамутдинов, Т. Р.,
Тимербулатов, Ш. В.,
Сибаев, В. М. (2022) The OBJECTIVE of the work was to study the incidence of general
surgical diseases, their structure